1. Murai, Yasuo, Matano, Fumihiro, Kubota, Asami, Nakae, Ryuta, Tamaki, Tomonori. . RNF213-Related Vasculopathy: Various Systemic Vascular Diseases Involving RNF213 Gene Mutations: Review. In Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 91, 140-145. doi:10.1272/jnms.JNMS.2024_91-215. https://pubmed.ncbi.nlm.nih.gov/38777780/
2. Liu, Wanyang, Morito, Daisuke, Takashima, Seiji, Hashimoto, Nobuo, Koizumi, Akio. 2011. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. In PloS one, 6, e22542. doi:10.1371/journal.pone.0022542. https://pubmed.ncbi.nlm.nih.gov/21799892/
3. Ye, Fei, Niu, Xingyang, Liang, Feng, Qi, Tiewei, Sheng, Wenli. . RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway. In Brain : a journal of neurology, 146, 4674-4689. doi:10.1093/brain/awad225. https://pubmed.ncbi.nlm.nih.gov/37399508/
4. Ihara, Masafumi, Yamamoto, Yumi, Hattori, Yorito, Tournier-Lasserve, Elisabeth, Koizumi, Akio. 2022. Moyamoya disease: diagnosis and interventions. In The Lancet. Neurology, 21, 747-758. doi:10.1016/S1474-4422(22)00165-X. https://pubmed.ncbi.nlm.nih.gov/35605621/
5. Roy, Vincent, Ross, Jay P, Pépin, Rémy, Dupré, Nicolas, Gros-Louis, François. 2022. Moyamoya Disease Susceptibility Gene RNF213 Regulates Endothelial Barrier Function. In Stroke, 53, 1263-1275. doi:10.1161/STROKEAHA.120.032691. https://pubmed.ncbi.nlm.nih.gov/34991336/
6. Jiang, Ning, Zhou, Jie, Zhang, Wenhao, Li, Yuliang, Zhao, Xiaogang. 2020. RNF213 gene mutation in circulating tumor DNA detected by targeted next-generation sequencing in the assisted discrimination of early-stage lung cancer from pulmonary nodules. In Thoracic cancer, 12, 181-193. doi:10.1111/1759-7714.13741. https://pubmed.ncbi.nlm.nih.gov/33200540/
7. Wang, Changshui, Sun, Cuilian, Zhao, Yueshu, Jin, Feng, Cui, Changmeng. 2021. RNF213 gene silencing upregulates transforming growth factor β1 expression in bone marrow-derived mesenchymal stem cells and is involved in the onset of Moyamoya disease. In Experimental and therapeutic medicine, 22, 1024. doi:10.3892/etm.2021.10456. https://pubmed.ncbi.nlm.nih.gov/34373710/